PHILADELPHIA, PA — Researchers at Temple University Lewis Katz School of Medicine say a little-known compound could mark a ...
Humans—and our ancestors—have been drinking alcohol for thousands of years, and likely becoming addicted to it for just as long. Yet, even as our understanding of the biological underpinnings of ...
CD19-directed CAR T-cell therapy can lead to sustained remission in DLBCL, but relapse is common, affecting up to 60% of patients. Epcoritamab, a bispecific T-cell engager, may enhance CAR T-cell ...
A young man in recovery from addiction once gave me his perspective on the painful consequences of relapse: “It’s not the relapse that troubles me,” he said. “It’s the self-beating that comes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results